End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.17 EUR | +3.06% |
|
+5.15% | +11.74% |
06-25 | German Stocks Fall Tuesday | DJ |
06-25 | Eckert & Ziegler Unit Gets 'Encouraging' Feedback from US FDA for Lead Diagnostic | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 29.45 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.6 times its current sales, is high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Office Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.74% | 1.02B | - | ||
+1.98% | 7.32B | B- | ||
-12.29% | 4.46B | B | ||
+0.44% | 3.18B | - | ||
+12.10% | 2.19B | - | ||
-37.03% | 986M | - | ||
+6.05% | 921M | - | ||
-56.79% | 712M | - | ||
-29.77% | 636M | - | - | |
-36.47% | 623M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EUZ Stock
- EUZ Stock
- Ratings Eckert & Ziegler SE